Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host
Clinical trial NCT02891395 · COMPLETED
Trial details
- NCT number
- NCT02891395
- Sponsor
- University Hospital, Lille
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-24
- Primary completion
- 2017-07-26
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.